The Cancer Letter

Inside information on cancer research and drug development

Karen Knudsen named CEO of the American Cancer Society

In Brief

David Tuveson inaugurated president of AACR; Lisa Coussens is president-elect
Ludwig Institute opens cancer metabolism branch at Princeton
Carl June receives $1M Sanford Lorraine Cross Award
Marcos J. de Lima named director of Bone Marrow Transplant Services at OSUCCC – James
Patrizia Cavazzoni named permanent director of FDA CDER
Mark Juckett named medical director of the Masonic’s immuno-oncology initiative

Drugs & Targets

Trodelvy receives FDA accelerated approval for advanced urothelial cancer
GI Genius receives marketing authorization from FDA to detect potential signs of colon cancer
Sacituzumab govitecan receives FDA approval for TNBC
FDA approves new dosing regimen for cetuximab
NCCN recognizes Oncotype DX test as the only multigene test to predict chemotherapy benefit in node-positive early-stage breast cancer
TriSalus Life Sciences, MD Anderson collaboration to evaluate treatment of solid tumors

In The Clinic

Trials & Tribulations

Setting a research agenda on cannabis and cannabinoids: Updates from the NCI symposium

Setting a research agenda on cannabis and cannabinoids: Updates from the NCI symposium
City of Hope leads Cancer Patients Bill of Rights resolution, aimed at expanding access to unleash the full benefits of cancer care innovation
FreeTrials & Tribulations
The Delaware experience:
FreeTrials & Tribulations
Tackling racial disparities through novel approaches to engage communities in research Keeping in contact with those at risk is key to colorectal and breast cancer screening during COVID-19
FreeTrials & Tribulations
An oncologist's perspective on measuring success in the clinic
Trials & Tribulations

Latest Issue

Read the latest issue

UPCOMING EVENTS

No post found

The Cancer Letter is an independent weekly news publication and the leading source for information on the issues that shape oncology.

Login

Looking for IP Login?